- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.04. | Novartis secures pair of regulatory wins for skin disease and malaria treatments | ||
| 27.04. | UK biotech could be bound for recovery, BIA report reveals | ||
| 27.04. | Sun Pharma to acquire Organon for $11.75bn | ||
| 24.04. | Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings | ||
| 24.04. | OZMOSI and Planview partner to enhance pharmaceutical data integration | ||
| 24.04. | Regeneron cuts White House pricing deal, offers new gene therapy for free | ||
| 24.04. | Cumberland to sell drug portfolio to Apotex for $100m | ||
| 23.04. | 500,000 patients' data for sale online after UK Biobank breach | ||
| 23.04. | Sanofi receives FDA approval for Tzield in paediatric diabetes | ||
| 23.04. | AbbVie opts for North Carolina to house $1.4bn manufacturing site | ||
| 23.04. | MSD teams up with Google Cloud on agentic AI transformation | ||
| 22.04. | Medicare weight loss drug pilot on ice as insurers decline to contribute | ||
| 22.04. | MSD-backed Ray locks in $125m to back eye drug pipeline | ||
| 22.04. | FDA approves MSD's once-daily HIV combo Idvynso | ||
| 22.04. | BioAegis and Prenosis partner for inflammatory disease therapies | ||
| 22.04. | Health Canada approves Biocon's two denosumab biosimilars | ||
| 21.04. | Eli Lilly doubles down on in vivo with $7bn Kelonia buyout | ||
| 21.04. | Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy | ||
| 21.04. | Asahi Kasei acquires German company Aicuris | ||
| 20.04. | British patients risking "fake" weight loss drugs, despite safety concerns, survey says | ||
| 20.04. | Boehringer Ingelheim launches AI centre in London | ||
| 20.04. | Trump backs psychedelics for mental health in new executive order | ||
| 20.04. | UCB to purchase Neurona and NRTX-1001 for $1.15bn | ||
| 20.04. | MSD secures EC approval for Enflonsia to prevent infant RSV infection | ||
| 17.04. | Kailera makes history with record-breaking $625m IPO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.